Gilead Sciences Other intangible assets—net decreased by 3.5% to $16.38B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $19.36B to $16.38B. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows a downward trend with a -12.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...
High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.
non_current_assets_intangible_assets_net_excluding_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $34.34B | $33.90B | $33.46B | $30.33B | $29.89B | $29.44B | $28.89B | $28.35B | $27.75B | $27.15B | $26.45B | $23.43B | $22.83B | $20.55B | $19.95B | $19.36B | $18.57B | $17.97B | $16.98B | $16.38B |
| QoQ Change | — | -1.3% | -1.3% | -9.3% | -1.5% | -1.5% | -1.9% | -1.9% | -2.1% | -2.2% | -2.6% | -11.4% | -2.5% | -10.0% | -2.9% | -3.0% | -4.1% | -3.2% | -5.5% | -3.5% |
| YoY Change | — | — | — | — | -13.0% | -13.2% | -13.6% | -6.5% | -7.1% | -7.8% | -8.4% | -17.4% | -17.7% | -24.3% | -24.6% | -17.4% | -18.7% | -12.5% | -14.9% | -15.4% |